Biomolecules

17 October 2024
Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Molecular Biomarkers”

As all of the articles published in our journal are open access, you have free and unlimited access to the full text. We welcome you to read our most highly cited papers published in 2022 and 2023, which are listed below:

1. “Lipid Peroxidation and Antioxidant Protection”
by Luca Valgimigli
Biomolecules 2023, 13(9), 1291; https://doi.org/10.3390/biom13091291
Full text available online: https://www.mdpi.com/2218-273X/13/9/1291

2. “Oxidative Stress in Healthy and Pathological Red Blood Cells”
by Florencia Orrico, Sandrine Laurance, Ana C. Lopez, Sophie D. Lefevre, Leonor Thomson, Matias N. Möller and Mariano A. Ostuni
Biomolecules 2023, 13(8), 1262; https://doi.org/10.3390/biom13081262
Full text available online: https://www.mdpi.com/2218-273X/13/8/1262

3. “Are There Betel Quid Mixtures Less Harmful than Others? A Scoping Review of the Association between Different Betel Quid Ingredients and the Risk of Oral Submucous Fibrosis”
by Nicola Cirillo, Peter Hung Duong, Wee Teng Er, Casey Thao Nhi Do, Manikkuwadura Eranda Harshan De Silva, Yining Dong, Sok Ching Cheong, Elizabeth Fitriana Sari, Michael J. McCullough, Pangzhen Zhang et al.
Biomolecules 2022, 12(5), 664; https://doi.org/10.3390/biom12050664
Full text available online: https://www.mdpi.com/2218-273X/12/5/664

4. “NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study”
by Laure Morimont, Mélanie Dechamps, Clara David, Céline Bouvy, Constant Gillot, Hélène Haguet, Julien Favresse, Lorian Ronvaux, Julie Candiracci, Marielle Herzog et al.
Biomolecules 2022, 12(8), 1038; https://doi.org/10.3390/biom12081038
Full text available online: https://www.mdpi.com/2218-273X/12/8/1038

5. “Relationship between 4-Hydroxynonenal (4-HNE) as Systemic Biomarker of Lipid Peroxidation and Metabolomic Profiling of Patients with Prostate Cancer”
by Matea Nikolac Perkovic, Morana Jaganjac, Lidija Milkovic, Tea Horvat, David Rojo, Kamelija Zarkovic, Marijana Ćorić, Tvrtko Hudolin, Georg Waeg, Biserka Orehovec et al.
Biomolecules 2023, 13(1), 145; https://doi.org/10.3390/biom13010145
Full text available online: https://www.mdpi.com/2218-273X/13/1/145

6. “Complement as a Biomarker for Systemic Lupus Erythematosus”
by Masahiro Ayano and Takahiko Horiuchi
Biomolecules 2023, 13(2), 367; https://doi.org/10.3390/biom13020367
Full text available online: https://www.mdpi.com/2218-273X/13/2/367

7. “Identification of Metabolism-Associated Biomarkers for Early and Precise Diagnosis of Oral Squamous Cell Carcinoma”
by Yuhan Wang, Xiaoxin Zhang, Shuai Wang, Zihui Li, Xinyang Hu, Xihu Yang, Yuxian Song, Yue Jing, Qingang Hu and Yanhong Ni
Biomolecules 2022, 12(3), 400; https://doi.org/10.3390/biom12030400
Full text available online: https://www.mdpi.com/2218-273X/12/3/400

8. “Impact of Polyphenols on Inflammatory and Oxidative Stress Factors in Diabetes Mellitus: Nutritional Antioxidants and Their Application in Improving Antidiabetic Therapy”
by Michal Krawczyk, Izabela Burzynska-Pedziwiatr, Lucyna A. Wozniak and Malgorzata Bukowiecka-Matusiak
Biomolecules 2023, 13(9), 1402; https://doi.org/10.3390/biom13091402
Full text available online: https://www.mdpi.com/2218-273X/13/9/1402

16 October 2024
MDPI's Newly Launched Journals in September 2024

Five new journals covering a diverse range of subjects launched their inaugural issue in September 2024. Like other journals in MDPI’s portfolio, these journals are dedicated to sharing the latest research through open access, reflecting our commitment to making knowledge accessible to all.

We extend our sincere gratitude to the Editorial Board Members for their dedication to the launch and development of our new journals. Each journal will ensure its high-quality output via excellent editorial and rigorous peer-review processes so that the published articles achieve significant impact and broad visibility.

We invite you to explore and learn more about these new journals below.

Journal	Founding Editor-in-Chief	Journal Topics (Selected)
	Prof. Dr. Nejat Düzgüneş, University of the Pacific, USA \| Editorial \| view inaugural issue	biological therapy and stem-cell therapy; drug therapy; chemotherapy; radiation and other nonsurgical therapeutic strategies \| view journal scope \| submit an article
	Prof. Dr. Magda Tsolaki, Greek Federation of Alzheimer’s Disease, Greece; Aristotle University of Thessaloniki, Greece \| Editorial \| view inaugural issue	surgical/procedural complications; complications; perioperative adverse events; postoperative adverse events \| view journal scope \| submit an article
	Prof. Dr. Steven R. Fassnacht, Colorado State University, USA; Cooperative Institute for Research in the Atmosphere, USA \| Editorial \| view inaugural issue	ice as a mineral; atmospheric ice; sea ice; freshwater ice; ice sheets; ice caps and ice shelves \| view journal scope \| submit an article
	Dr. Francisco Epelde, Hospital Universitari Parc Tauli, Spain; University Autonoma of Barcelona, Spain \| Editorial \| view inaugural issue	hospital management; hospital facilities; hospital services; hospital risk management; health law \| view journal scope \| submit an article
	Prof. Dr. Nicola Ferri, University of Padova, Italy \| Editorial \| view inaugural issue	lipids in cells and whole organisms; lipid structure and function; lipid products and processes; dietary lipids and nutrition \| view journal scope \| submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here or contact the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.

4 October 2024
MDPI INSIGHTS: The CEO's Letter #16 - UNGA79 Science Summit, OASPA, Peer Review Week

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.

Opening Thoughts

MDPI Joins the Science Summit at UNGA79 (23–27 September 2024, New York)

On Friday 27 September, I had the privilege of giving the opening talk at the “Youth at the Science Summit” panel during the Science Summit conference, held in New York at the 79th session of the United Nations General Assembly (UNGA). Together, we discussed the future of science, publishing, innovation, and sustainable development.

It was a great opportunity to learn from our young leaders, whose voices must be included in the conversation as science shapes the future of artificial intelligence, climate mitigation, healthcare, technology, and more. This was also a powerful reminder of how essential global collaboration is in solving the major challenges we face. I left inspired by the dedication of these young researchers to making the world a better place!

Today’s youth are not just the leaders of tomorrow – they are already leading the change today.

Stefan Tochev (second from left) at the UNGA Science Summit 2024: “A great opportunity to learn from our young leaders.”

MDPI Supports the Future Generation of Scientists

This aligns with MDPI’s mission to support the next generation of scientists and early-career researchers by recognizing their achievements through our various MDPI awards, including the Young Investigator Awards, Best PhD Thesis Awards, Travel Awards, and more.

Our presence at this global event showed our commitment to advancing Open Science as a key driver for sustainable development. As a leading Open Access (OA) publisher, MDPI’s role at the summit was to emphasize the critical importance of democratizing scientific knowledge, making it accessible to all, and promoting global collaboration.

Through OA publishing, we aim to address pressing global challenges such as climate change, public health, and inequality, in line with the United Nations Sustainable Development Goals (SDGs).

“We aim to address pressing global challenges”

MDPI and the SDGs

In 2020, the SDG Publishers Compact was launched to accelerate implementation of the SDGs by promoting content that informs, develops, and inspires action. MDPI joined this initiative in 2021 and subsequently launched the MDPI SDG Hub in 2022, offering free access to recent research within the scope of each of the 17 SDGs.

During the summit, we highlighted the connection between Open Science and the SDG Publishers Compact, supporting the core objective to “Leave No One Behind” (LNOB). The transformative promise of the SDGs relies heavily on the Open Access model, which serves as a fundamental enabler of Open Science. We advocate for the wider adoption of Open Science practices in order to achieve the SDGs by 2030.

Impactful Research

Presenting at the 1st International Conference of Environmental Medicine

In September, MDPI and our journals IJERPH and Diseases sponsored and participated in the 1st International Conference of Environmental Medicine: Environmental Threats to Human Health: From Genetics to Epigenetics, held in Chieti, Italy.

The conference was organized in collaboration with various societies, including the Italian Society of Environmental Medicine (SIMA), one of more than 160 societies partnering MDPI journals.

The conference brought together influential figures from the Italian scholarly community, such as Antonio Felice Uricchio (President of the National Agency for University Research Assessment [ANVUR]), Alessandro Miani (President of SIMA), and Liborio Stuppia (Director of ‘Gabriele d’Annunzio’ University of Chieti-Pescara), among others.

MDPI was the sole publishing sponsor of the conference, at which I had the opportunity to present on behalf of the company. I provided an overview of MDPI, covering key facts and figures, the peer-review process, our strong collaboration with the Italian market, and insights into Nobel Prize winners who have published with MDPI, ahead of Sir Richard Roberts’ Nobel lecture.

“As at September 2024, 44 Nobel laureates have contributed to over 115 articles across 35 MDPI journals”

The keynote speaker at the event was Sir Richard Roberts, Nobel Laureate and 1993 Nobel Prize winner in Medicine, recognized for his discovery of split genes.

Nobel Laureates’ Contributions to MDPI

As at September 2024, 44 Nobel laureates have contributed to over 115 articles across 35 MDPI journals. I’ll share more details on this in the October newsletter.

Hosting such prominent figures in their respective fields, who play a significant role in advancing the OA movement, of which we are leaders in, resonates deeply with our editorial teams.

Sponsoring and supporting academic conferences is something we do on a large scale, and it continues to grow. Attending and speaking about MDPI shows our commitment by taking the time to connect with the scholarly community in person.

MDPI’s Presence in Italy

Italy ranks third globally in total MDPI publications, with nearly 130,000 contributions. We collaborate with about 12,000 Editorial Board Members in Italy, over 6,100 of whom have an H-index of more than 25.

We have 83 Editors-in-Chief and 209 Section Editors-in-Chief from Italy. We also support 20 Italian universities through our Institutional Open Access Program (IOAP) agreements with major institutions such as Sapienza University of Rome, the University of Milan, and the University of Pisa, among others.

Inside MDPI

Celebrating Peer Review Week, 23–27 September 2024

As we conclude another productive month at MDPI, I am pleased to highlight our participation in this year’s Peer Review Week (PRW), which took place from 23–27 September 2024. This global, community-driven celebration underscores the vital importance of peer review in maintaining the integrity and reliability of academic work. PRW provide a platform for institutions, publishers, and scholars to come together and reflect on the processes that uphold the quality of scholarly communication.

“We remain committed to enhancing the peer review process”

The theme for PRW 2024 was ‘Innovation and Technology in Peer Review.’ At MDPI, we were proud to contribute through various online and in-person events, including webinars from Europe, Asia-Pacific, and a roundtable discussion on innovation and technology in peer review. These events offer an opportunity to explore new tools and technologies that are shaping the future of peer review, particularly the integration of AI. As a company, we remain committed to enhancing the peer review process with innovative solutions while preserving the essential human expertise that makes it effective.

Peer Review Innovation and Technology at MDPI

Our efforts to improve peer review extend beyond the activities of this week. We also released a blog article discussing New Tools for Advancing Research Integrity and Peer Review, where we highlight two tools that MDPI has developed to support research integrity: Eureka – Reviewer Recommender and Online Proofreader. We are continually refining SuSy, our in-house submission system, to provide a seamless experience for authors and reviewers alike.

Listening to MDPI’s Authors and Reviewers

We highly value the time of our reviewers, and so do the authors who contribute to our journals. Our editorial process is bolstered by a network of dedicated reviewers, a team of over 6,000 diligent, well-trained staff members, and an in-house article submission platform designed to ensure efficient processes.

We make it a point to continually improve the experiences of both our authors and our reviewers throughout the entire editorial process, from submission to publication. This is why we regularly ask for feedback by conducting surveys. Here is what some of our respondents recently had to say about working with MDPI:

Coming Together for Science

ICM 2024 – Advances in Material Innovation

I am pleased to share that we held The 5th International Conference on Materials: Advances in Material Innovation (ICM 2024) in Basel, Switzerland this past 25–27 September.

This intimate event brought together leading scientists, researchers, and industry experts to exchange insights on recent advancements in materials characterization, processing, and manufacturing. Key focus areas included nanotechnology in material sciences and engineering, optical, electrical, and magnetic materials, soft, biological, and biomaterials, fibres, membranes, thin films, sensing materials, as well as materials and devices for energy and solar fuels. In addition, discussions featured the integration of AI and machine learning in materials research.

We received 90 abstract submissions. Over the course of the three-day event, 18 posters were displayed, and 34 talks were delivered, including three plenary speeches, seven invited talks, and 24 selected oral presentations.

A special thank-you to our partnering societies The Polish Membrane Society and The North American Thermal Analysis Society, as well as our sponsor, Nanomegas, for their support of the ICM conference. I am also pleased to share that we presented three awards, including the Best Presentation Award and two Best Poster Awards, recognizing the outstanding contributions of our participants.

Upcoming In-Person Event

7–9 October 2024
Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines
Location: Basel, Switzerland

ncRNA 2024 will explore the latest advances in the field, covering topics from basic biology to medical and technological applications.

Find more upcoming MDPI events here.

Closing Thoughts

Reflections from OASPA 2024 Conference in Lisbon (16–18 September)

Amidst my September travels, I also had pleasure of attending the OASPA 2024 Conference in Lisbon from 16–18 September. It’s the first in-person Open Access Scholarly Publishing Association (OASPA) event in five years, and being in the sunny city of Lisbon made it even better! MDPI has long been a member of OASPA, and attending this conference gave us an opportunity to connect with other key members of the organization to see the latest developments in the OA movement.

“I believe that publishers have a lot to offer in terms of data and insights”

Main Themes from OASPA 2024

The main themes covered were equity and inclusivity, diamond OA, AI and openness, OA books, research integrity, and how OA can address broader societal challenges such as climate change. While it was great to see the latest developments in these areas, it was also clear that certain voices were missing, particularly those of major publishers. Although it’s not easy to incorporate every perspective, I believe that publishers, including MDPI, have a lot to offer in terms of data and insights. During the membership meeting, a few of us raised the point that large-scale publisher input could add value to these discussions.

It’s important to participate in industry conferences such as OASPA in order to be part of the discussions and remain at the forefront of the OA movement.

It’s an opportunity to build meaningful relationships with organizations that share our commitment to OA.

While sponsorship is one way to show our support, it’s clear that being part of the conversation through participating in the OASPA groups and committee is what really makes a difference.

It took the last 20 years for more than 50% of the world's research to be published via open access. This provides a sobering reminder that flipping the remaining 50% will be a big challenge.

An important takeaway for me was that there is no "one-size-fits-all" solution for OA challenges: different regions and different stakeholders need different forms of support, whether it is infrastructure, funding, education, or policy, for example. I also enjoyed Rebecca Ross' presentation on how OA can drive action on climate. A few panellists shared the need for transparency in the peer-review process, advocating for open review reports, which is something we have been offering since 2014.

Speaking of openness, we are excited to celebrate Open Access Week 2024 with the scholarly community from 21–27 October. I look forward to sharing a recap of our activities in the next newsletter.

Stefan Tochev
Chief Executive Officer
MDPI AG

29 September 2024
MDPI New Journal Proposal—Invitation to Shape the Future of Open Science Together

As a leader in open access publishing, MDPI is eager to explore new collaboration opportunities, including the launch of new journals and the transfer of existing ones. At present, MDPI publishes over 400 journals, more than 160 of which have established partnerships with academic organizations. Additionally, we publish 19 association journals.

In order to enhance exchange and cooperation with scientific researchers and share the results of open science, MDPI invites experts and scholars from various fields to submit proposals for new journal collaboration opportunities. If your proposal is approved, you could take on the role of Editor-in-Chief, Deputy Editor-in-Chief, or Editorial Board Member of the journal. This position allows you to manage the manuscript review process alongside our editorial department, participate in calls for papers, strengthen your network with scholars in the field, expand scientific research cooperation, enhance your personal and academic influence internationally, and play a leading role in academia.

Once the new journal is online, MDPI will provide a variety of promotional channels to market the journal internationally.

MDPI will offer various promotional channels to enhance its visibility and promote it internationally.

How can you determine the theme of a new journal?

Assess research hotspots/academic frontiers;
Assess pioneers in the field/key research directions of universities;
Determine whether MDPI has already established a journal in the field.

You can browse MDPI’s existing journals at the following link: https://www.mdpi.com/about/journals.

Advantages of collaborating with MDPI:

MDPI is a global leader in open-access publishing with extensive academic resources.
MDPI offers a professional publishing team that provides comprehensive support throughout the publishing process.
MDPI’s diverse promotional platforms and channels help journals quickly increase their international visibility and influence.

We invite you to submit new journal proposal here, and contribute to academic development! In addition, if your institution (university, institute, college, national key laboratory, society, etc.) intends to establish a journal, you can also submit a draft to MDPI on its behalf.

27 September 2024
MDPI’s 2023 Travel Awards—Winners Announced

MDPI journals frequently grant travel awards to empower junior researchers to showcase their latest research at academic conferences, thereby amplifying their impact within their research fields.

We extend our heartfelt congratulations to the 103 recipients of MDPI's 2023 Travel Awards from different countries and territories for their exceptional presentations. These outstanding individuals were selected by the journal editors based on the strength of their research proposals and the anticipated impact of their presentations at academic conferences. We commend their exceptional contributions and wish them continued success in their academic endeavors.

MDPI will continue to provide support and recognition to the academic community. To learn more about the list of awardees, please visit the following pages:

About MDPI Awards:

To reward the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

11 September 2024
Meet Us at the Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines, 7–9 October 2024, Basel, Switzerland

MDPI will be attending the Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines (ncRNA 2024) in Basel, Switzerland, which will take place from 7 to 9 October 2024. The conference will cover a broad range of topics, from basic biology to medical and technological applications. The sessions will take molecular biology through the topics of disease mechanisms, therapies, technologies, and bioinformatic approaches. Each session will be anchored by leading international speakers.

The following MDPI journals will be represented:

Biology;
Biomedicines;
Biomolecules;
Cells;
Epigenomes;
Genes;
Life.

If you are attending the conference, please visit our booth. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following link: https://sciforum.net/event/ncRNA2024.

11 September 2024
MDPI’s 2023 Best PhD Thesis Awards—Winners Announced

MDPI’s Best PhD Thesis Awards are granted to promising young scholars whose PhD theses are deemed exceptional within their respective research fields. These awards aim to encourage young scholars to continue their outstanding accomplishments and further contribute to their field.

We extend our heartfelt congratulations to the 54 winners of the 2023 Best PhD Thesis Awards and wish them success with their future research endeavors.

MDPI will continue to provide support and recognition to the academic community. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:

Biology and life sciences;

Chemistry and materials sciences;

Computer sciences and mathematics;

Engineering;

Environmental and earth sciences;

Medicine and pharmacology;

Social sciences, arts and humanities;

Others.

About MDPI Awards:

To reward the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and are making a significant contribution to the advancement of their fields.

To explore more MDPI awards, please click here.

10 September 2024
Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Chemical Biology”

As all of the articles published in our journal are open access, you have free and unlimited access to the full text. We welcome you to read our most highly cited papers published in 2022 and 2023, which are listed below.

1. “PI3K–AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds”
by Yeqin Yuan, Huizhi Long, Ziwei Zhou, Yuting Fu and Binyuan Jiang
Biomolecules 2023, 13(1), 93; https://doi.org/10.3390/biom13010093
Full text available online: https://www.mdpi.com/2218-273X/13/1/93

2. “The Multifaceted Role of Aquaporin-9 in Health and Its Potential as a Clinical Biomarker”
by Inês V. da Silva, Sabino Garra, Giuseppe Calamita and Graça Soveral
Biomolecules 2022, 12(7), 897; https://doi.org/10.3390/biom12070897
Full text available online: https://www.mdpi.com/2218-273X/12/7/897

3. “Macrophages in Skin Wounds: Functions and Therapeutic Potential”
by Seen Ling Sim, Snehlata Kumari, Simranpreet Kaur and Kiarash Khosrotehrani
Biomolecules 2022, 12(11), 1659; https://doi.org/10.3390/biom12111659
Full text available online: https://www.mdpi.com/2218-273X/12/11/1659

4. “Rosmarinic Acid and Related Dietary Supplements: Potential Applications in the Prevention and Treatment of Cancer”
by Jiachao Zhao, Liwei Xu, Di Jin, Yu Xin, Lin Tian, Tan Wang, Daqing Zhao, Zeyu Wang and Jing Wang
Biomolecules 2022, 12(10), 1410; https://doi.org/10.3390/biom12101410
Full text available online: https://www.mdpi.com/2218-273X/12/10/1410

5. “Vitamin D3 Stimulates Proliferation Capacity, Expression of Pluripotency Markers, and Osteogenesis of Human Bone Marrow Mesenchymal Stromal/Stem Cells, Partly through SIRT1 Signaling”
by Ana Borojević, Aleksandra Jauković, Tamara Kukolj, Slavko Mojsilović, Hristina Obradović, Drenka Trivanović, Milena Živanović, Željko Zečević, Marija Simić, Borko Gobeljić et al.
Biomolecules 2022, 12(2), 323; https://doi.org/10.3390/biom12020323
Full text available online: https://www.mdpi.com/2218-273X/12/2/323

6. “Cytochromes P450 of Caenorhabditis elegans: Implication in Biological Functions and Metabolism of Xenobiotics”
by Lucie Larigot, Daniel Mansuy, Ilona Borowski, Xavier Coumoul and Julien Dairou
Biomolecules 2022, 12(3), 342; https://doi.org/10.3390/biom12030342
Full text available online: https://www.mdpi.com/2218-273X/12/3/342

7. “Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders”
by Pradeep Jayarajan Ramakrishna, Anil Shinde, Abdul Rasheed Mohammed, Venkata Ramalingayya Grandhi, Vijay Benade, Vinod Kumar Goyal, Renny Abraham, Venkat Jasti and Jeffrey Cummings
Biomolecules 2023, 13(2), 309; https://doi.org/10.3390/biom13020309
Full text available online: https://www.mdpi.com/2218-273X/13/2/309

8. “The Complex Biological Effects of Pectin: Galectin-3 Targeting as Potential Human Health Improvement?”
by Lucas de Freitas Pedrosa, Avraham Raz and João Paulo Fabi
Biomolecules 2022, 12(2), 289; https://doi.org/10.3390/biom12020289
Full text available online: https://www.mdpi.com/2218-273X/12/2/289

9. “Biomarker Characterization and Prediction of Virulence and Antibiotic Resistance from Helicobacter pylori Next Generation Sequencing Data”
by Joana S. Vital, Luís Tanoeiro, Ricardo Lopes-Oliveira and Filipa F. Vale
Biomolecules 2022, 12(5), 691; https://doi.org/10.3390/biom12050691
Full text available online: https://www.mdpi.com/2218-273X/12/5/691

10. “Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present”
by Sarah E. Huff, Jordan M. Winter and Chris G. Dealwis
Biomolecules 2022, 12(6), 815; https://doi.org/10.3390/biom12060815
Full text available online: https://www.mdpi.com/2218-273X/12/6/815

10 September 2024
Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Molecular Biology”

As all of the articles published in our journal are open access, you have free and unlimited access to the full text. We welcome you to read our most highly cited papers published in 2022 and 2023, which are listed below.

1. “Molecular Biomarkers in Cancer”
by Virinder Kaur Sarhadi and Gemma Armengol
Biomolecules 2022, 12(8), 1021; https://doi.org/10.3390/biom12081021
Full text available online: https://www.mdpi.com/2218-273X/12/8/1021

2. “Recent Advances in Poly(α-L-glutamic acid)-Based Nanomaterials for Drug Delivery”
by Yu Zhang, Wenliang Song, Yiming Lu, Yixin Xu, Changping Wang, Deng-Guang Yu and Il Kim
Biomolecules 2022, 12(5), 636; https://doi.org/10.3390/biom12050636
Full text available online: https://www.mdpi.com/2218-273X/12/5/636

3. “Melittin-Based Nano-Delivery Systems for Cancer Therapy”
by Anqi Wang, Yuan Zheng, Wanxin Zhu, Liuxin Yang, Yang Yang and Jinliang Peng
Biomolecules 2022, 12(1), 118; https://doi.org/10.3390/biom12010118
Full text available online: https://www.mdpi.com/2218-273X/12/1/118

4. “Recent Advances in Strategies for Addressing Hypoxia in Tumor Photodynamic Therapy”
by Liang Hong, Jiangmin Li, Yali Luo, Tao Guo, Chenshuang Zhang, Sha Ou, Yaohang Long and Zuquan Hu
Biomolecules 2022, 12(1), 81; https://doi.org/10.3390/biom12010081
Full text available online: https://www.mdpi.com/2218-273X/12/1/81

5. “Targeting Oxidative Stress Involved in Endometriosis and Its Pain”
by Lauren Clower, Taylor Fleshman, Werner J. Geldenhuys and Nalini Santanam
Biomolecules 2022, 12(8), 1055; https://doi.org/10.3390/biom12081055
Full text available online: https://www.mdpi.com/2218-273X/12/8/1055

6. “Role of Fibroblasts and Myofibroblasts on the Pathogenesis and Treatment of Pelvic Organ Prolapse”
by Zeliha Guler and Jan Paul Roovers
Biomolecules 2022, 12(1), 94; https://doi.org/10.3390/biom12010094
Full text available online: https://www.mdpi.com/2218-273X/12/1/94

7. “Methacrylated Cartilage ECM-Based Hydrogels as Injectables and Bioinks for Cartilage Tissue Engineering”
by Kevin Behan, Alexandre Dufour, Orquidea Garcia and Daniel Kelly
Biomolecules 2022, 12(2), 216; https://doi.org/10.3390/biom12020216
Full text available online: https://www.mdpi.com/2218-273X/12/2/216

8. “Cellulose Nanofiber-Based Aerogels from Wheat Straw: Influence of Surface Load and Lignin Content on Their Properties and Dye Removal Capacity”
by Ramón Morcillo-Martín, Eduardo Espinosa, Laura Rabasco-Vílchez, Laura M. Sanchez,Jorge de Haro and Alejandro Rodríguez
Biomolecules 2022, 12(2), 232; https://doi.org/10.3390/biom12020232
Full text available online: https://www.mdpi.com/2218-273X/12/2/232

9. “Wood Waste from Fruit Trees: Biomolecules and Their Applications in Agri-Food Industry”
by Maria Jose Aliaño-González, Julien Gabaston, Victor Ortiz-Somovilla and Emma Cantos-Villar
Biomolecules 2022, 12(2), 238; https://doi.org/10.3390/biom12020238
Full text available online: https://www.mdpi.com/2218-273X/12/2/238

10. “Effects of Glucose Metabolism, Lipid Metabolism, and Glutamine Metabolism on Tumor Microenvironment and Clinical Implications”
by Longfei Zhu, Xuanyu Zhu and Yan Wu
Biomolecules 2022, 12(4), 580; https://doi.org/10.3390/biom12040580
Full text available online: https://www.mdpi.com/2218-273X/12/4/580

10 September 2024
Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Molecular Genetics”

As all of the articles published in our journal are open access, you have free and unlimited access to the full text. We welcome you to read our most highly cited papers published in 2022 and 2023, which are listed below.

1. “Folic Acid, Folinic Acid, 5 Methyl TetraHydroFolate Supplementation for Mutations That Affect Epigenesis through the Folate and One-Carbon Cycles”
by Yves Menezo, Kay Elder, Arthur Clement and Patrice Clement
Biomolecules 2022, 12(2), 197; https://doi.org/10.3390/biom12020197
Full text available online: https://www.mdpi.com/2218-273X/12/2/197

2. “Acetylation, Phosphorylation, Ubiquitination (Oh My!): Following Post-Translational Modifications on the Ubiquitin Road”
by Rachel E. Lacoursiere, Dania Hadi and Gary S. Shaw
Biomolecules 2022, 12(3), 467; https://doi.org/10.3390/biom12030467
Full text available online: https://www.mdpi.com/2218-273X/12/3/467

3. “Plasma Exosome-Derived microRNAs as Potential Diagnostic and Prognostic Biomarkers in Brazilian Pancreatic Cancer Patients”
by Anelis Maria Marin, Sibelle Botogosque Mattar, Rafaela Ferreira Amatuzzi, Roger Chammas, Miyuki Uno, Dalila Luciola Zanette and Mateus Nóbrega Aoki
Biomolecules 2022, 12(6), 769; https://doi.org/10.3390/biom12060769
Full text available online: https://www.mdpi.com/2218-273X/12/6/769

4. “Glycemic Control and the Heart: The Tale of Diabetic Cardiomyopathy Continues”
by Miriam Longo, Lorenzo Scappaticcio, Paolo Cirillo, Antonietta Maio, Raffaela Carotenuto, Maria Ida Maiorino, Giuseppe Bellastella and Katherine Esposito
Biomolecules 2022, 12(2), 272; https://doi.org/10.3390/biom12020272
Full text available online: https://www.mdpi.com/2218-273X/12/2/272

5. “Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes”
by Cristina Mazzaccara, Raffaella Lombardi, Bruno Mirra, Ferdinando Barretta, Maria Valeria Esposito, Fabiana Uomo, Martina Caiazza, Emanuele Monda, Maria Angela Losi, Giuseppe Limongelli et al.
Biomolecules 2022, 12(10), 1417; https://doi.org/10.3390/biom12101417
Full text available online: https://www.mdpi.com/2218-273X/12/10/1417

6. “Optimized AAV Vectors for TMC1 Gene Therapy in a Humanized Mouse Model of DFNB7/11”
by Irina Marcovich, Nicholas K. Baer, Olga Shubina-Oleinik, Rachel Eclov, Clayton W. Beard and Jeffrey R. Holt
Biomolecules 2022, 12(7), 914; https://doi.org/10.3390/biom12070914
Full text available online: https://www.mdpi.com/2218-273X/12/7/914

7. “Myocardial Inflammation as a Manifestation of Genetic Cardiomyopathies: From Bedside to the Bench”
by Giovanni Peretto, Elena Sommariva, Chiara Di Resta, Martina Rabino, Andrea Villatore, Davide Lazzeroni, Simone Sala, Giulio Pompilio and Leslie T. Cooper
Biomolecules 2023, 13(4), 646; https://doi.org/10.3390/biom13040646
Full text available online: https://www.mdpi.com/2218-273X/13/4/646

8. “Advances and Challenges in Spatial Transcriptomics for Developmental Biology”
by Kyongho Choe, Unil Pak, Yu Pang, Wanjun Hao and Xiuqin Yang
Biomolecules 2023, 13(1), 156; https://doi.org/10.3390/biom13010156
Full text available online: https://www.mdpi.com/2218-273X/13/1/156

9. “Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes”
by Federica Zatterale, Gregory Alexander Raciti, Immacolata Prevenzano, Alessia Leone, Michele Campitelli, Veronica De Rosa, Francesco Beguinot and Luca Parrillo
Biomolecules 2022, 12(7), 982; https://doi.org/10.3390/biom12070982
Full text available online: https://www.mdpi.com/2218-273X/12/7/982

10. “Grapevine DMR6-1 Is a Candidate Gene for Susceptibility to Downy Mildew”
by Carlotta Pirrello, Giulia Malacarne, Marco Moretto, Luisa Lenzi, Michele Perazzolli, Tieme Zeilmaker, Guido Van den Ackerveken, Stefania Pilati, Claudio Moser and Lisa Giacomelli
Biomolecules 2022, 12(2), 182; https://doi.org/10.3390/biom12020182
Full text available online: https://www.mdpi.com/2218-273X/12/2/182

Journal	Founding Editor-in-Chief	Journal Topics (Selected)
	Prof. Dr. Nejat Düzgüneş, University of the Pacific, USA \| Editorial \| view inaugural issue	biological therapy and stem-cell therapy; drug therapy; chemotherapy; radiation and other nonsurgical therapeutic strategies \| view journal scope \| submit an article
	Prof. Dr. Magda Tsolaki, Greek Federation of Alzheimer’s Disease, Greece; Aristotle University of Thessaloniki, Greece \| Editorial \| view inaugural issue	surgical/procedural complications; complications; perioperative adverse events; postoperative adverse events \| view journal scope \| submit an article
	Prof. Dr. Steven R. Fassnacht, Colorado State University, USA; Cooperative Institute for Research in the Atmosphere, USA \| Editorial \| view inaugural issue	ice as a mineral; atmospheric ice; sea ice; freshwater ice; ice sheets; ice caps and ice shelves \| view journal scope \| submit an article
	Dr. Francisco Epelde, Hospital Universitari Parc Tauli, Spain; University Autonoma of Barcelona, Spain \| Editorial \| view inaugural issue	hospital management; hospital facilities; hospital services; hospital risk management; health law \| view journal scope \| submit an article
	Prof. Dr. Nicola Ferri, University of Padova, Italy \| Editorial \| view inaugural issue	lipids in cells and whole organisms; lipid structure and function; lipid products and processes; dietary lipids and nutrition \| view journal scope \| submit an article

Journal Menu

Journal Browser

Announcements

17 October 2024
Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Molecular Biomarkers”

16 October 2024
MDPI's Newly Launched Journals in September 2024

4 October 2024
MDPI INSIGHTS: The CEO's Letter #16 - UNGA79 Science Summit, OASPA, Peer Review Week

Welcome to the MDPI Insights: The CEO's Letter.

Opening Thoughts

Impactful Research

Inside MDPI

Coming Together for Science

Closing Thoughts

29 September 2024
MDPI New Journal Proposal—Invitation to Shape the Future of Open Science Together

27 September 2024
MDPI’s 2023 Travel Awards—Winners Announced

11 September 2024
Meet Us at the Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines, 7–9 October 2024, Basel, Switzerland

11 September 2024
MDPI’s 2023 Best PhD Thesis Awards—Winners Announced

10 September 2024
Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Chemical Biology”

10 September 2024
Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Molecular Biology”

10 September 2024
Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Molecular Genetics”

Further Information

Guidelines

MDPI Initiatives

Follow MDPI

Journal Menu

Journal Browser

Announcements

17 October 2024 Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Molecular Biomarkers”

16 October 2024 MDPI's Newly Launched Journals in September 2024

4 October 2024 MDPI INSIGHTS: The CEO's Letter #16 - UNGA79 Science Summit, OASPA, Peer Review Week

Welcome to the MDPI Insights: The CEO's Letter.

Opening Thoughts

Impactful Research

Inside MDPI

Coming Together for Science

Closing Thoughts

29 September 2024 MDPI New Journal Proposal—Invitation to Shape the Future of Open Science Together

27 September 2024 MDPI’s 2023 Travel Awards—Winners Announced

11 September 2024 Meet Us at the Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines, 7–9 October 2024, Basel, Switzerland

11 September 2024 MDPI’s 2023 Best PhD Thesis Awards—Winners Announced

10 September 2024 Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Chemical Biology”

10 September 2024 Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Molecular Biology”

10 September 2024 Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Molecular Genetics”

Further Information

Guidelines

MDPI Initiatives

Follow MDPI

17 October 2024
Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Molecular Biomarkers”

16 October 2024
MDPI's Newly Launched Journals in September 2024

4 October 2024
MDPI INSIGHTS: The CEO's Letter #16 - UNGA79 Science Summit, OASPA, Peer Review Week

29 September 2024
MDPI New Journal Proposal—Invitation to Shape the Future of Open Science Together

27 September 2024
MDPI’s 2023 Travel Awards—Winners Announced

11 September 2024
Meet Us at the Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines, 7–9 October 2024, Basel, Switzerland

11 September 2024
MDPI’s 2023 Best PhD Thesis Awards—Winners Announced

10 September 2024
Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Chemical Biology”

10 September 2024
Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Molecular Biology”

10 September 2024
Biomolecules | Highly Cited Papers in 2022–2023 in the Section “Molecular Genetics”